New Leukemia Drug Approved: Gives Hope To Cancer Patients
The United States Food and Drug Administration has approved a new leukemia treatment today. It was produced by Teva Pharmaceutical Industries Ltd under the brand name Synribo. The drug is known as omacetaxine mepesuccinate and it treats a very specific form of leukemia. The type of cancer is called chronic myelogenous, which affects the blood […]
1 min read